State Of Wyoming Repligen Corp Transaction History

State Of Wyoming

$676 Million
Q3 2024

A detailed history of State Of Wyoming transactions in Repligen Corp stock. As of the latest transaction made, State Of Wyoming holds 2,163 shares of RGEN stock, worth $308,076. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,163

Previous 1,647 31.33%

Holding current value

$308,076

Previous $207,000 55.07%

% of portfolio

0.05%

Previous 0.03%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$119.79 - $167.35 $61,811 - $86,352	516 Added 31.33%	2,163 $321,000
Q2 2024 Aug 14, 2024	BUY	$120.0 - $182.95 $10,800 - $16,465	90 Added 5.78%	1,647 $207,000
Q1 2024 May 13, 2024	BUY	$170.78 - $208.42 $31,935 - $38,974	187 Added 13.65%	1,557 $286,000
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $18,153 - $29,470	159 Added 13.13%	1,370 $246,000
Q3 2023 Nov 14, 2023	BUY	$138.78 - $176.51 $60,508 - $76,958	436 Added 56.26%	1,211 $192,000
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $16,610 - $21,637	120 Added 18.32%	775 $109,000
Q1 2023 May 12, 2023	SELL	$154.26 - $198.1 $8,484 - $10,895	-55 Reduced 7.75%	655 $110,000
Q4 2022 Feb 14, 2023	BUY	$162.42 - $220.56 $20,464 - $27,790	126 Added 21.58%	710 $120,000
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $13,956 - $22,290	87 Added 17.51%	584 $109,000
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $11,676 - $15,605	83 Added 20.05%	497 $81,000
Q1 2022 May 13, 2022	BUY	$161.19 - $257.96 $6,769 - $10,834	42 Added 11.29%	414 $78,000
Q4 2021 Feb 11, 2022	SELL	$247.59 - $304.47 $56,945 - $70,028	-230 Reduced 38.21%	372 $99,000
Q3 2021 Feb 11, 2022	SELL	$194.77 - $324.21 $41,680 - $69,380	-214 Reduced 26.23%	602 $174,000
Q2 2021 Feb 11, 2022	BUY	$165.87 - $220.95 $135,349 - $180,295	816 New	816 $163,000

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.3M

Call Options Held

350K

Put Options Held

184K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.9B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.

Account